DMIIR NASDAQ
Drugs Made In America Acquisition II Corp.
1W: -8.1%
1M: -20.1%
3M: -32.5%
YTD: -57.2%
$0.06
-0.00 (-6.55%)
Weekly Expected Move ±35.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$9M
Net Income
+0.0% YoY
$-0M
Free Cash Flow
+0.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE1.8%
ROA1.7%
ROIC-0.0%
Valuation
P/E0.3
P/B0.0
EV/EBITDA-17.5
Leverage
Debt/Equity0.00
Current Ratio0.34
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman-B10.10
Beneish M0.00